Cold Chain Pharmaceuticals Market Shows Steady Growth with Technological Push and Expanding Global Trade
FAQ's
Answer : The global monoclonal antibodies market size was reached at US$ 177.46 billion in 2021 and it is expected to rake round US$ 524.68 billion by 2030.
Answer : The global monoclonal antibodies market is expected to drive growth at a CAGR of 12.8% from 2022 to 2030.
Answer : The major players operating in the monoclonal antibodies market are Johnson & Johnson, Merck, AbbVie, Amgen, GlaxoSmithKline plc., Norvatis AG, Pfizer Inc., Thermofischer Scientific, Elililly and Company, Bristol-Myers Squibb
Answer : The rising cases of cancer and other chronic diseases among the global population is expected to drive the demand for the monoclonal antibodies and foster the market growth during the forecast period.
Answer : The North America region hit highest revenue share of 45% in 2021 and will lead the global monoclonal antibodies market.
Get a Sample of this Report
Cold Chain Pharmaceuticals Market
